Search
MSU prof breaks ground with childhood cancer discovery
- OPACC
- Jan 8, 2016
- 1 min read
Today the drug is in clinical trials in 24 U.S. hospitals. Patient trials are aimed at assessing the drug's effectiveness against neuroblastoma. If successful, it could help raise the survival rate for children battling an often unforgiving disease.
Recent Posts
See AllDuring cancer treatment, children can face hurdles to maintaining healthy eating. Chemotherapy has many side effects, including loss of...
Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
Comments